Fabrice Gouilleux

Université de Tours — France

Medicine · Health Sciences

45h-index8.5kcitations121works15.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(63), NF-κB Signaling Pathways(17), Chronic Myeloid Leukemia Treatments(16), Acute Myeloid Leukemia Research(13), PI3K/AKT/mTOR signaling in cancer(10)

Publications121 total

Novel antileukemic compound with sub-micromolar potency against STAT5 addicted myeloid leukemia cells
European Journal of Medicinal Chemistry·2024· 1 citedOpen Access
Targeted Therapeutic Strategies for the Treatment of Cancer
Cancers·2024· 44 citedOpen Access
Novel Antileukemic Compound with Sub-Micromolar Potency Against Stat5 Addicted Myeloid Leukemia Cells
SSRN Electronic Journal·2024Open Access
Diphenyleneiodonium Triggers Cell Death of Acute Myeloid Leukemia Cells by Blocking the Mitochondrial Respiratory Chain, and Synergizes with Cytarabine
Cancers·2022· 6 citedOpen Access
Diphenyleneiodonium Triggers Cell Death of Acute Myeloid Leukaemia Cells by Blocking the Mitochondrial Respiratory Chain and Synergizes with Cytarabine
Preprints.org·2021· 1 citedOpen Access
Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases
Molecules·2021· 3 citedOpen Access
Design, synthesis, and antiproliferative effect of 2,9‐bis[4‐(pyridinylalkylaminomethyl)phenyl]‐1,10‐phenanthroline derivatives on human leukemic cells by targeting G‐quadruplex
Archiv der Pharmazie·2021· 10 citedOpen Access
Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines: A Correlation with the Differentiation Status
Antioxidants·2021· 17 citedOpen Access
CCDC 2051185: Experimental Crystal Structure Determination
The Cambridge Structural Database·2021Open Access
CCDC 2051186: Experimental Crystal Structure Determination
The Cambridge Structural Database·2021Open Access
New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation
Molecules·2021· 21 citedOpen Access
Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential
ChemMedChem·2020· 7 citedOpen Access
Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature
Blood Advances·2020· 16 citedOpen Access
Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment
Current Medicinal Chemistry·2020· 31 citedOpen Access
VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines
International Journal of Molecular Sciences·2020· 11 citedOpen Access
Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells
Journal of Cellular and Molecular Medicine·2020· 12 citedOpen Access
STAT5 is Expressed in CD34+/CD38− Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms
Cancers·2020· 16 citedOpen Access
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
Cancers·2020· 70 citedOpen Access
A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells
Cancers·2019· 21 citedOpen Access
Correction: Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells
Oncogene·2019· 3 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Bernd Groner(21), Richard Moriggl(11), Valérie Gouilleux‐Gruart(10), Sylvie Gisselbrecht(9), Isabelle Dusanter‐Fourt(7), Kaı̈ss Lassoued(6), Marc A. Kerenyi(5), Peter Valent(5), Hiroshi Wakao(4), C. Pallard(4), Patrick Mayeux(4), Stéphanie Dumon(4), Susana Constantino Rosa Santos(4), Noria Harir(4), Jérôme Bourgeais(4), Lothar Hennighausen(3), J Delobel(3), R Weber-Nordt(3), Susanne Berchtold(3), Virginie Penard‐Lacronique(3)